Related Experiment Video
Updated: Jul 29, 2026

Three-dimensional Confocal Analysis of Microglia/macrophage Markers of Polarization in Experimental Brain Injury
Published on: September 4, 2013
METTL14 regulates microglia/macrophage polarization and NLRP3 inflammasome activation after ischemic stroke by the
Yamei Li1, Jiacen Li2, Qian Yu1
1Department of Rehabilitation Medicine, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu 610072, Sichuan, China.
Abstract:
N6-methyladenosine (m6A) plays a crucial role in ischemic stroke, whereas the role of methyltransferase-like 14 (METTL14) in ischemic stroke remains unknown. A model of middle cerebral artery occlusion (MCAO) in rats and oxygen-glucose deprivation/reperfusion (OGD/R) model in HAPI cells were used to simulate ischemic stroke in vivo and in vitro. We found that METTL14 level was upregulated in microglia/macrophage after MCAO and OGD/R. METTL14 enhanced the expression of KAT3B by promoting the m6A modification of KAT3B mRNA. STING has been identified as a target for KAT3B and KAT3B increased STING expression by enhancing H3K27ac in the STING promoter. METTL14 promoted M1 polarization and NLRP3 inflammasome/pyroptosis axis by the KAT3B-STING signaling after OGD/R. METTL14 depletion relieved brain injury by inhibiting M1-like microglia/macrophage polarization and NLRP3 inflammasome/pyroptosis axis in MCAO rats. These findings indicate that METTL14 depletion relieves MCAO-induced brain injury, probably via switching microglia/macrophage from M1 towards M2 and restraining NLRP3 inflammasome/pyroptosis axis in microglia/macrophage.
Insights
Methyltransferase-like 14 (METTL14) promotes ischemic stroke brain injury by upregulating M1 microglia polarization and the NLRP3 inflammasome/pyroptosis axis. METTL14 depletion alleviates injury by inhibiting these pathways.
Area of Science:
- Neuroscience
- Molecular Biology
- Immunology
Background:
- N6-methyladenosine (m6A) is vital in ischemic stroke.
- The specific role of methyltransferase-like 14 (METTL14) in ischemic stroke is currently unknown.
Purpose of the Study:
- To investigate the role of METTL14 in ischemic stroke.
- To elucidate the underlying molecular mechanisms of METTL14 in brain injury.
Main Methods:
- In vivo middle cerebral artery occlusion (MCAO) rat model.
- In vitro oxygen-glucose deprivation/reperfusion (OGD/R) in HAPI cells.
- Analysis of METTL14, KAT3B, STING, and H3K27ac expression and modification.
Main Results:
- METTL14 expression was upregulated in microglia/macrophages post-MCAO and OGD/R.
- METTL14 enhanced KAT3B expression via m6A modification of KAT3B mRNA.
- KAT3B increased STING expression by enhancing H3K27ac at the STING promoter.
- METTL14 promoted M1 polarization and the NLRP3 inflammasome/pyroptosis axis through the KAT3B-STING pathway.
- METTL14 depletion reduced brain injury in MCAO rats by inhibiting M1-like microglia/macrophage polarization and the NLRP3 inflammasome/pyroptosis axis.
Conclusions:
- METTL14 depletion alleviates MCAO-induced brain injury.
- METTL14 likely shifts microglia/macrophage polarization from M1 to M2.
- METTL14 depletion restrains the NLRP3 inflammasome/pyroptosis axis in microglia/macrophages.

